Crossmark

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study

Crossref DOI link: https://doi.org/10.1186/s12913-019-4260-5

Published Online: 2019-06-24

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Jie http://orcid.org/0000-0002-4996-2556
Arden, Madelynne

Hoo, Zhe Hui

Wildman, Martin
Funding

Funding for this research was provided by:

National Institute for Health Research (RP-PG-1212-20015)
License Information

Text and Data Mining valid from 2019-06-24

Version of Record valid from 2019-06-24
More Information

Article History

Received: 17 May 2019

Accepted: 13 June 2019

First Online: 24 June 2019

Ethics approval and consent to participate

: Study 1 received approval from North of Scotland Research Ethics Committee (17/NS/0038). Study 2 received approval from London Brent Research Ethics Committee (16/LO/0356). All participants signed informed consent form about voluntary participation in the study.

: Consent for publication is not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below